Margareta Hagman

Filings at 3 companies/Chief financial officer · Isofol Medical AB (publ)

All 3 shown

This page is free to read, and it stops after 3 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Isofol Medical AB (publ) Chief financial officer
102,400 SEKOpen-market buy
TradedSep 23, 2024FiledSep 23, 2024
Infant Backterial Therapeutics AB Board member
93,410 SEKOpen-market buy
TradedMay 13, 2024FiledMay 13, 2024
BioGaia AB Chief financial officer, Deputy chief executive officer
1,386,000 SEKOpen-market sale
TradedMay 21, 2019FiledMay 21, 2019